or Try an Advanced Search...

    Monoclonal Antibody Stocks List

    Symbol Grade Name % Change
    ZURA F Zura Bio Limited -6.83
    ZBIO F Zenas BioPharma, Inc. 14.94
    CGEN F Compugen Ltd. -2.76
    IPHA F Innate Pharma S.A. -4.12
    ATXS F Astria Therapeutics, Inc. 3.32
    SYRE F Spyre Therapeutics, Inc. 2.59
    IMVT F Immunovant, Inc. 1.24
    ANNX F Annexon, Inc. -0.58
    DNTH F Dianthus Therapeutics, Inc. 10.21
    CLDX F Celldex Therapeutics, Inc. 3.05
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Long-Term Care Facilities
    Related Stock Lists: Immunology Antibody Biopharmaceutical Biotechnology Antibodies Immune System Medicine Monoclonal Antibodies Autoimmune Disease Cancer Clinical Medicine Autoimmunity Biomarkers Cancer Treatment Complement System Eye Immunotherapy Life Sciences Multiple Sclerosis Treatment Of Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibody stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 4.14
    XPH B SPDR S&P Pharmaceuticals ETF 3.94
    PBE C PowerShares Dynamic Biotech & Genome 3.78
    PJP C PowerShares Dynamic Pharmaceuticals 3.62
    YOLO F AdvisorShares Pure Cannabis ETF 3.28
    View all Monoclonal Antibody ETFs...
    Compare ETFs
    Compare FTXH to PBE Compare PJP to YOLO Compare XPH to PJP

        Monoclonal Antibody Stocks Recent News

        Date Stock Title
        Nov 21 IMVT Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 DNTH Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 20 IPHA Innate Pharma Releases Its 2025 Financial Calendar
        Nov 19 ANNX The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate.
        Nov 19 SYRE Spyre Therapeutics announces pricing of $200 million public offering of common stock
        Nov 19 IPHA Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
        Nov 19 SYRE Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
        Nov 18 SYRE Spyre Therapeutics announces proposed secondary offering
        Nov 18 SYRE Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Long-Term Care Facilities
        Related Stock Lists: Biopharmaceutical Biotechnology Immunology Life Sciences Medicine Clinical Medicine Antibodies Cancer Monoclonal Antibodies Clinical Development Drugs Health Sciences Host Disease Immune System Lymphoma Pharmaceutical Products Schizophrenia Specialty Drugs Treatment Of Cancer Acute Lymphoblastic Leukemia
        Monoclonal Antibody

        A monoclonal antibody is a type of antibody that is made from a single clone of cells and is specific to a single antigen. Monoclonal antibodies are used in medical research and in the treatment of various diseases, such as cancer and autoimmune disorders. They are produced by fusing a single B-cell with a myeloma cell, which results in a hybrid cell that produces a single type of antibody. Monoclonal antibodies can be used to target specific antigens on cells, allowing researchers to study the function of the antigen and its role in disease. They can also be used to deliver drugs or toxins to specific cells, making them useful in cancer treatments.

        Browse All Tags